precision medeccine Flashcards
most common genetic mutations associated with breast cancer
BRCA1
BRCA 2
CHEK 2
what are the main methods associated with DNA sequence
PCR
Sanger - NGS
probes : Microarray
pros of
Sanger vs NGS
sanger - cheap method with high precision that has a short turnaround time
NGS - is able to study thee whole genome and exomes
and has broad adaptability
results on microarray
A homozygote for a mutation will have a more intense spot than a heterozygote for the same mutation
what is the choice for diagnosticc method for patients with breast or ovarian cancer & for population screening
PCR
what is the most appropriate diagnostic method for detecting microsatellite instability
IHC or PCR
what diagnostic method can be used for multigene analysis
NGS
problem with mis-sense mutations that are classified as variants of uncertain significance ?
may be disease predisposing
what is the mandatory procedure associated with CRC patients that are considered for cetuximab anpanitumumab treatment ?
must first perform KRAS and NRAS testing
mutations ? no benefit
wild type ? some form of benfit
what is microsatellite instability
phenotype feature of cancer which develops due to deficiency of DNA mismatch repair ( MMR)
what is the first line treatmeent for MSI high neeoplasms ?
MSI high ( microsatellite instability )
immunotheerapy
Anti-PDL1
pembrolizumab
Protein markers are not truly tumor-specific but
tissue specific
what are the three levels associated with risk assessment in hereditary breast cancer ?
high risk HBC
intermediate risk HBC
low risk HBC
features of intermediate risk for HBC
two 1st or 2nd degree on same side of the family with breast cancer below thee age of 70 or ovarian cancer of any age
or
one 1st or 2nd degree relatives with breast cancer aged 35-49
features of high risk for HBC
relatives with BRCA1 or BRCA2 mutations
* Two relatives on the same side of the family with breast cancer <50 or ovarian cancer (any age)
- One 1st/2nd degree relative with breast cancer:
* <35 years
* Bilateral, first before age 50
* Breast and ovarian cancer (any age)
* Male breast cancer